Brian J Brille sold $12M of CAI
See Remarks at Caris Life Sciences, Inc.. 400,000 shares at an average of $30.33, traded Sep 17, 2026, filed Sep 17, 2026.
Score components
- +15RoleOfficer
- +25Trade size$12.1M at market
- +20Share of holdings soldSold 63% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002071959-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | MOption exercise Common Stock | +400,000 | $2.44 | $976k | 630,303 | 25 d ago |
| Sep 17, 2026 | SOpen-market sale Common Stock | -400,000 | $30.33 | $12M | 230,303 | 25 d ago |
| Sep 17, 2026 | MOption exercise Stock Optionderivative | -400,000 | $0.00 | $0 | 1,600,000 | 25 d ago |
Related signals
Other insiders at Caris Life Sciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | Caris Life Sciences, Inc. | John Russel Denton See Remarks | $239k 7,500 shares | -4% | |
| 48Moderate | Caris Life Sciences, Inc. | David Baxley Spetzler President | $15M 597,212 shares | -39% | |
| 59Moderate | Caris Life Sciences, Inc. | Brian J Brille See Remarks | $630k 30,000 shares | +23% | |
| 47Moderate | Caris Life Sciences, Inc. | John Russel Denton See Remarks | $158k 7,500 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.